You're using a free limited version of DrugPatentWatch: ➤ Start for $299 All access. No Commitment.

Last Updated: December 14, 2025

List of Excipients in API ACYCLOVIR


✉ Email this page to a colleague

« Back to Dashboard


Excipients in NDA-approved (novel) drugs containing ACYCLOVIR

Glossary
Company Tradename Ingredient NDC Excipient Potential Generic Entry
Teva Pharmaceuticals USA Inc ACYCLOVIR acyclovir 0093-3630 CETOSTEARYL ALCOHOL
Teva Pharmaceuticals USA Inc ACYCLOVIR acyclovir 0093-3630 MINERAL OIL
Teva Pharmaceuticals USA Inc ACYCLOVIR acyclovir 0093-3630 PETROLATUM
Teva Pharmaceuticals USA Inc ACYCLOVIR acyclovir 0093-3630 POLOXAMER 407
Teva Pharmaceuticals USA Inc ACYCLOVIR acyclovir 0093-3630 PROPYLENE GLYCOL
>Company >Tradename >Ingredient >NDC >Excipient >Potential Generic Entry

Subscribe to access the full database, or Get Started Free

Excipients in ANDA-approved (generic) drugs containing ACYCLOVIR

Company Ingredient NDC Excipient
E Fougera & Co a division of Fougera Pharmaceuticals Inc acyclovir 0168-0825 POLYETHYLENE GLYCOL
Mylan Pharmaceuticals Inc acyclovir 0378-8700 POLYETHYLENE GLYCOL
Liberty Pharmaceuticals Inc acyclovir 0440-7033 CELLULOSE, MICROCRYSTALLINE
Liberty Pharmaceuticals Inc acyclovir 0440-7033 CROSCARMELLOSE SODIUM
Liberty Pharmaceuticals Inc acyclovir 0440-7033 MAGNESIUM STEARATE
>Company >Ingredient >NDC >Excipient

Subscribe to access the full database, or Get Started Free

Detailed excipient profiles for ACYCLOVIR

Excipient focus: ALCOHOL

Excipient focus: ALUMINUM OXIDE

Excipient focus: AMMONIA

Excipient focus: BANANA

Excipient focus: BROWN IRON OXIDE

Excipient focus: BUTYL ALCOHOL

Excipient focus: CARBOXYMETHYLCELLULOSE SODIUM

Excipient focus: CELLULOSE, MICROCRYSTALLINE

Excipient focus: CETOSTEARYL ALCOHOL

Excipient focus: CITRIC ACID MONOHYDRATE

Excipient focus: CROSCARMELLOSE SODIUM

Excipient focus: CROSPOVIDONE

Excipient focus: D&C RED NO. 28

Excipient focus: D&C RED NO. 33

Excipient focus: D&C YELLOW NO. 10

Excipient focus: FD&C BLUE NO. 1

Excipient focus: FD&C BLUE NO. 2

Excipient focus: FD&C RED NO. 3

Excipient focus: FD&C RED NO. 40

Excipient focus: FD&C YELLOW NO. 6

Excipient focus: FERRIC OXIDE RED

Excipient focus: FERROSOFERRIC OXIDE

Excipient focus: GELATIN

Excipient focus: GLYCERIN

Excipient focus: HYDROCHLORIC ACID

Excipient focus: HYPROMELLOSE 2208

Excipient focus: INDIGOTINDISULFONATE SODIUM

Excipient focus: ISOPROPYL ALCOHOL

Excipient focus: ISOPROPYL MYRISTATE

Excipient focus: LACTOSE MONOHYDRATE

Excipient focus: MAGNESIUM STEARATE

Excipient focus: METHYLPARABEN

Excipient focus: MINERAL OIL

Excipient focus: NITROGEN

Excipient focus: NONCRYSTALLIZING SORBITOL SOLUTION

Excipient focus: PETROLATUM

Excipient focus: POLOXAMER 188

Excipient focus: POLOXAMER 407

Excipient focus: POLYETHYLENE GLYCOL

Excipient focus: POLYETHYLENE GLYCOL 1450

Excipient focus: POLYETHYLENE GLYCOL 300

Excipient focus: POTASSIUM HYDROXIDE

Excipient focus: POVIDONE

Excipient focus: POVIDONE K25

Excipient focus: POVIDONE K30

Excipient focus: POVIDONES

Excipient focus: PROPYLENE GLYCOL

Excipient focus: PROPYLPARABEN

Excipient focus: SHELLAC

Excipient focus: SILICON DIOXIDE

Excipient focus: SODIUM HYDROXIDE

Excipient focus: SODIUM LAURETH SULFATE

Excipient focus: SODIUM LAURETH-3 SULFATE

Excipient focus: SODIUM LAURYL SULFATE

Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO

Excipient focus: SORBITOL

Excipient focus: SORBITOL SOLUTION

Excipient focus: STARCH, CORN

Excipient focus: STARCH, PREGELATINIZED CORN

Excipient focus: TALC

Excipient focus: TITANIUM DIOXIDE

Excipient focus: WATER

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

 
© Copyright 2002-2025 thinkBiotech LLC
ISSN: 2162-2639
Secure SSL Encrypted
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
 NCE-1 Patent Challenge Dates 2025 - 2026
Preferred Citation:

Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
   See Primary Research Papers Citing DrugPatentWatch

Links